From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children
Variables | Non AAC group | AAC group† | Pvalue |
---|---|---|---|
(n = 43) | (n = 24) | ||
WBC (/mm3) | 13,590 (5,680 ~ 30,300) | 13,930 (4,000 ~ 23,620) | 0.870 |
Neutrophils (%) | 78.6 (29.3 ~ 95.2) | 84.3 (37.5 ~ 95.3) | 0.392 |
Hemoglobin (g/dL) | 11.6 (8.7 ~ 14.2) | 11.8 (10.0 ~ 14.8) | 0.985 |
Platelet count (/mm3) | 354,000 (175,000 ~ 573,000) | 274,000 (64,000 ~ 492,000) | 0.007* |
Albumin (g/dL) | 3.9 (2.7 ~ 4.6) | 3.4 (2.6 ~ 4.3) | 0.001* |
Total bilirubin (mg/dL) | 1.1 (0.2 ~ 5.7) | 2.6 (0.2 ~ 5.4) | 0.172 |
Direct bilirubin (mg/dL) | 2.1 (0.1 ~ 5.3) | 2.4 (1.6 ~ 4.1) | 0.704 |
AST (IU/L) | 84 (19 ~ 1,287) | 109 (27 ~ 1,003) | 0.729 |
ALT (IU/L) | 159 (6 ~ 898) | 167 (25 ~ 1,076) | 0.870 |
γGT (IU/L) | 219 (23 ~ 577) | 189 (20 ~ 450) | 1.000 |
ESR (mm/h) | 44.5 (6 ~ 120) | 38 (3 ~ 114) | 1.000 |
CRP (mg/dL) | 8.0 (0.6 ~ 26.0) | 9.4 (0.2 ~ 26.0) | 0.392 |
PT INR | 1.2 (1.0 ~ 1.5) | 1.2 (1.0 ~ 10.9) | 0.460 |
aPTT (sec) | 43.6 (33.2 ~ 58.7) | 45.9 (26.8 ~ 57.7) | 0.440 |